REFERENCES
- Chan TM, Lok ASF, Cheng IKP, Chan RT. Prevalence of hepatitis C virus infection in hemodialysis patients: a longitudinal study comparing the results of RNA and antibody assays. Hepatology. 1993; 17: 5–8
- Zeldis JB, Depner TA, Kuramoto IK, Gish RG, Holland PV. The prevalence of hepatitis C virus antibodies among hemodialysis patients. Ann Intern Med. 1990; 112(12)958–960
- Donahue JG, Munoz A, Ness PM, et al. The declining risk of post-transfusion hepatitis C virus infection. New Engl J Med. 1992; 327: 369–373
- Sampietro M, Badalamenti S, Salvadori S, et al. High prevalence of a rare hepatitis C virus in patients treated in the same hemodialysis unit: evidence of nosocomial transmission of HCV. Kidney Int. 1995; 47: 911–917
- Allander T, Medin C, Jacobson SH, Grillner L, Persson MA. Hepatitis C transmission in a hemodialysis unit: molecular evidence for spread of virus among patients not sharing equipment. J Med Virol. 1994; 415–419
- Jaboul M, Cornu C, Van Ypersele de Strihou C, UCL Collaborative Group. Universal precautions prevent hepatitis C virus transmission: a 54 month follow up of the Belgian multicenter study. Kidney Int. 1998; 53: 1022–1025
- Geerlings W, Tufverson G, Ehrich JH, et al. Report on management of renal failure in Europe XXIII. Nephrol Dial Transplant. 1994; 43: 108–119
- Lauer GM, Walker TL, Cooper S. Acute hepatitis C. Hepatology. 2001; 345: 41–52
- Meyers CM, Seeff LB, Stehman-Breen CO, Hoofnagle JH. Hepatitis C and renal disease: an update. Am J Kid Dis. 2003; 42: 631–657
- Major ME, Mihalic K, Fernandez J, et al. Long term follow up of chimpanzees inoculated with the first infectious clone for hepatitis C virus. J Virol. 1999; 73: 3317–3325
- Centers for Disease Control and Prevention. Recommendations for preventing transmission of infectious among hemodialysis patients. MMWR Morbid Mortal Wkly Rep. 2001; 50: 1–43
- Puro V, Petrosillo N, Ippolito G, for the Italian Study Group on Occupational Risk for HIV and Other Bloodborne Infections. Risk of hepatitis C seroconversion after occupational exposures in health care workers. Am J Infect Control. 1995; 23: 273–277
- Bukh J, Miller RH, Pursell RH. Genetic heterogeneity of hepatitis C virus: quasispecies and genotypes. Semin Liver Dis. 1995; 15: 41–63
- Mondelli MU, Sillini E. Clinical significance of hepatitis C virus genotypes. J Hepatol. 2000; 31: 65–70
- Silini EM, Bono F, Cividina A, et al. Differential distribution of hepatitis C virus genotypes in patients with and without liver function abnormalities. Hepatology. 1995; 21: 959–965
- Gerlach TJ, Zachoval R, Gruener N, Jung M-C, Ulsenheimer A, Schraut W, Scrirren A, et al. Acute hepatitis C: a natural course and response to antiviral treatment. Hepatology. 2001; 34: 341A
- Ohnishi K, Nomura F, Nakamo M. Interferon therapy for acute posttransfusion non-A, non-B hepatitis: response with respect to anti-hepatitis C virus antibody status. Am J Gastroenterol. 1991; 86: 1041–1049
- Alberti A. Interferon therapy of acute hepatitis C. Viral Hepatitis Reviews. 1995; 1: 37–45
- Hoofmagle JH. Therapy for acute hepatitis C. N Engl J Med. 2001; 345: 1495–1497